Key result
Alternatives to inhaled nitric oxide show potential for managing acute and chronic pulmonary hypertension.
Why the study?
What are the alternative pharmacological agents to inhaled nitric oxide for the management of pulmonary hypertension?
Population
Adult and paediatric patients with a variety of conditions associated with pulmonary hypertension, with or…
Design
Review
Authors
Loading...
Supports evaluation of alternatives in pulmonary hypertension; leaves open routine adoption without randomized comparisons.
What are the alternative pharmacological agents to inhaled nitric oxide for the management of pulmonary hypertension?
This review highlights various pharmacological alternatives to inhaled nitric oxide, such as prostacyclins and phosphodiesterase inhibitors, for managing pulmonary hypertension.
Stuart M. Lowson (2004) conducted a review in Pulmonary hypertension. Alternatives to inhaled nitric oxide (prostacyclins, phosphodiesterase inhibitors, endothelin antagonists) vs. Inhaled nitric oxide was evaluated. Alternative agents to inhaled nitric oxide, including prostacyclins, phosphodiesterase inhibitors, and endothelin antagonists, show potential for managing acute and chronic pulmonary hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: